- recruitingPHASE2
A Trial of Lu AG13909 in Adult Participants With Cushing's Disease
This study is testing a new medicine called Lu AG13909 for adults with Cushing's disease. We want to see if it lowers high cortisol levels, if it's safe, and how the body handles the medicine. It's for people aged 18-70 with this condition.
United States · France · Georgia - ongoing, recruitingTherapeutic exploratory (Phase II)
A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's disease
This study is looking at a medicine called Isturisa for children and teenagers with Cushing's disease. Researchers want to understand how the medicine works in the body, its effects, and if it's safe and well-tolerated for this age group.
France · Belgium · Italy